Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
10/2010
10/07/2010WO2010113495A1 C6orf167 peptides and vaccines containing the same
10/07/2010WO2010113148A1 Adenylyl cyclase-associated protein (cap1) and uses thereof as a target for immuno-modulation
10/07/2010WO2010112777A1 Method for assaying prodefensin-a6 for the in vitro diagnosis of colorectal cancer
10/07/2010WO2010112458A1 Composition and methods of use for therapeutic antibodies specific for the il-12 receptore betal subunit
10/07/2010WO2010112413A1 Treatment of cancer with a humanized anti-egfr igg1 antibody and irinotecan
10/07/2010WO2010112194A1 Antigen-binding polypeptides and multispecific antibodies comprising them
10/07/2010WO2010112193A1 Multispecific antibodies comprising full length antibodies and single chain fab fragments
10/07/2010WO2010112110A1 Anti-icam-1 antibody, uses and methods
10/07/2010WO2010111842A1 Antigenic determinants recognized by anti-human death receptor dr5 monoclonal antibody ad5-10, derivatives and uses thereof
10/07/2010WO2010111746A1 Anti-vegf-d antibodies
10/07/2010WO2010086828A3 Agonist anti-trkb monoclonal antibodies
10/07/2010WO2010079510A3 Anti-rhd monoclonal antibodies
10/07/2010WO2010065578A3 POLYPEPTIDES COMPRISING Fc FRAGMENTS OF IMMUNOGLOBULIN G (IgG) AND METHODS OF USING THE SAME
10/07/2010WO2010056898A3 Rapid expression cloning of human monoclonal antibodies from memory b cells
10/07/2010WO2010056043A3 Cell-penetrating, sequence-specific and nucleic acid-hydrolyzing antibody, method for preparing the same and pharmaceutical composition comprising the same
10/07/2010WO2001079455A9 Kv10.1, A NOVEL VOLTAGE-GATED POTASSIUM CHANNEL FROM HUMAN BRAIN
10/07/2010US20100256343 Immobilization particles for targeted removal of microorganisms and substances
10/07/2010US20100256341 Treatment of inflammation using alpha 7 receptor-binding cholinergic agonists
10/07/2010US20100256340 Trivalent, bispecific antibodies
10/07/2010US20100256339 Bispecific Anti ErbB3 / Anti cMet Antibodies
10/07/2010US20100256338 Multispecific antibodies comprising full length antibodies and single chain fab fragments
10/07/2010US20100256337 Method for purifying an fc-containing protein
10/07/2010US20100256336 Reduce the level of glycation of such polypeptides produced in cell culture by keeping concentration of a reducing sugar in the cell culture; biodrug production such as monoclonal antibodies
10/07/2010US20100256301 Peptide and protein preservation method
10/07/2010US20100256071 CHD5 encoding nucleic acids, polypeptides, antibodies and methods of use thereof
10/07/2010US20100256068 Antibodies and molecules derived therefrom that bind to STEAP-1 proteins
10/07/2010US20100256037 Polypeptides Having Cellobiohydrolase I Activity and Polynucleotides Encoding Same
10/07/2010US20100256014 Novel as160-like protein, test systems, methods and uses involving it for the identification of diabetes type 2 therapeutics
10/07/2010US20100255608 Isolated grp94 ligand binding domain polypeptide and nucleic acid encoding same, crystalline form of same, and screening methods employing same
10/07/2010US20100255574 Human Secreted Proteins
10/07/2010US20100255539 Engineered Antibody-Stress Protein Fusions
10/07/2010US20100255538 Antibodies to insulin-like growth factor i receptor
10/07/2010US20100255537 Nucleic acid molecules encoding beta-like glycoprotein hormone polypeptide and heterodimer thereof
10/07/2010US20100255518 Highly sensitive system and methods for analysis of troponin
10/07/2010US20100255515 Elisa for vegf
10/07/2010US20100255514 Tumor cell-derived microvesicles
10/07/2010US20100255507 Antibodies and other ligands directed against kir2dl4 receptor for production of interferon gamma
10/07/2010US20100255504 Reactive Heterocycle-Substituted 7-Hydroxycoumarins and Their Conjugates
10/07/2010US20100255502 Methods for Detecting and Inhibiting Angiogenesis
10/07/2010US20100255488 Fret-labeled compounds and uses therefor
10/07/2010US20100255472 Biomarkers for prostate cancer
10/07/2010US20100255081 Method for treating symptoms of diabetes
10/07/2010US20100255037 Novel sequences of haemonchus contortus, immunogenic compositions, methods for preparation and use thereof
10/07/2010US20100255034 Streptococcus Pyogenes Antigens
10/07/2010US20100255018 Polynucleotides and polypeptides involved in gestational malaria, and biological applications
10/07/2010US20100255014 Protein Complex Using An Immunoglobulin Fragment and Method For The Preparation Thereof
10/07/2010US20100255013 Glycoprotein compositions
10/07/2010US20100255012 Recombinant fucose modified monovalent half-antibodies obtained by molecular engineering
10/07/2010US20100255011 Compositions and methods for modulating the activity of complement regulatory proteins on target cells
10/07/2010US20100255010 Anti-her antibodies
10/07/2010US20100255009 Methods for Inducing Mixed Donor-Recipient Chimerism in an Allograft Transplant Recipient
10/07/2010US20100255008 Antibodies against human tweak and uses thereof
10/07/2010US20100255007 Therapeutic agents for graft-versus-host disease comprising interleukin 6 receptor inhibitor as active ingredient
10/07/2010US20100255006 Novel molecules of the pyrin/nbs/lrr protein family and uses thereof
10/07/2010US20100255000 Antidotes for factor xa inhibitors and methods of using the same
10/07/2010US20100254999 Eg-vegf nucleic acids and polypeptides and methods of use
10/07/2010US20100254998 Method for prolonging longevity
10/07/2010US20100254995 Polypeptides, antibody variable domains and antagonists
10/07/2010US20100254994 Compositions and Methods for Binding or Inactivating Ghrelin
10/07/2010US20100254993 Human monoclonal antibodies against human il-4
10/07/2010US20100254992 Anti-mcp-1 antibodies, compositions, methods and uses
10/07/2010US20100254990 Anti-ngf antibodies for the treatment of various disorders
10/07/2010US20100254989 Bispecific Anti ErbB1 / Anti c Met Antibodies
10/07/2010US20100254988 Bispecific Anti ErbB2 / Anti cMet Antibodies
10/07/2010US20100254987 Engineered proteins with high affinity for dota chelates
10/07/2010US20100254986 Method for making heteromultimeric polypeptides
10/07/2010US20100254982 Cancer specific antibody and cell surface proteins
10/07/2010US20100254980 Molecules and methods for modulating low-density-lipoprotein receptor-related protein 6 (lrp6)
10/07/2010US20100254979 Humanized PAI-1 Antibodies and Uses Thereof
10/07/2010US20100254978 Antibody molecules having specificity for human ox40
10/07/2010US20100254977 Engineered anti-alpha v-integrin hybrid antibodies
10/07/2010US20100254975 Alpha-4 beta-7 heterodimer specific
10/07/2010US20100254972 Methods for selecting protease resistant polypeptides
10/07/2010US20100254964 Modified Bouganin Proteins, Cytotoxins and Methods and Uses Thereof
10/07/2010US20100254946 Maintenance of hair growth and treatment of hair-loss
10/07/2010US20100254943 Amino acid substituted molecules
10/07/2010US20100254899 Radiolabeled affibody molecules
10/07/2010US20100254898 ANTIBODIES THAT BIND GalNAc1-3Gal, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USING SAME
10/07/2010CA2759942A1 Composition and methods of use for therapeutic antibodies specific for the il-12 receptore betai subunit
10/07/2010CA2757333A1 Mouse models
10/07/2010CA2757210A1 C6orf167 peptides and vaccines containing the same
10/07/2010CA2757175A1 Diagnosis of gluten-induced autoimmune diseases
10/07/2010CA2757114A1 Preparation of isolated agonist anti-edar monoclonal antibodies
10/07/2010CA2757095A1 Bmp-alk3 antagonists and uses for promoting bone growth
10/07/2010CA2756988A1 Anti-fcrh5 antibodies and immunoconjugates and methods of use
10/07/2010CA2756889A1 Monoclonal antibody capable of binding to specific discontinuous epitope occurring in ad1 region of human cytomegalovirus gb glycoprotein, and antigen-binding fragment thereof
10/07/2010CA2756762A1 Adenylyl cyclase-associated protein (cap1) and uses thereof as a target for immuno-modulation
10/07/2010CA2756244A1 Multispecific antibodies comprising full length antibodies and single chain fab fragments
10/07/2010CA2756156A1 Method for assaying prodefensin-a6 for the in vitro diagnosis of colorectal cancer
10/07/2010CA2754646A1 Treatment of cancer with a humanized anti-egfr igg1 antibody and irinotecan
10/07/2010CA2752908A1 Treatment of insulin-resistant disorders
10/07/2010CA2749512A1 Antigenic determinants recognized by anti-human death receptor dr5 monoclonal antibody ad5-10, derivatives and use thereof
10/06/2010EP2237041A1 Detection of a therapeutic antibody in an experimental animal
10/06/2010EP2237035A2 Taxol derivatives for taxol immunoassay
10/06/2010EP2236611A1 Lipolytic enzyme variant
10/06/2010EP2236608A2 Novel peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity
10/06/2010EP2236605A1 Human anti- 9 integrin antibody
10/06/2010EP2236604A1 Anti-nr10 antibody and use thereof
10/06/2010EP2236519A1 Human GM-CSF antigen binding proteins
10/06/2010EP2236518A2 Humaneered anti-factor B antibody
1 ... 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 ... 1494